Silesia Laboratorios

Laboratorios Silesia is a prominent Chilean pharmaceutical company specializing in women's health, gynecology, and hormone replacement therapies. As a subsidiary of Laboratorios Andrómaco (which was acquired by the German multinational pharmaceutical company Grünenthal in 2013), Silesia manufactures and distributes a wide range of oral contraceptives, hormone therapies, and bioequivalent medications. The company is well-known for introducing innovative combination hormone replacement therapies in Chile and operates out of Santiago. Silesia's portfolio includes notable products such as Anulette CD, Tinelle, and Progering, serving both the private retail market and public health sectors in Latin America.